tirzepatide success Keep Weight Off After Tirzepatide: Long-Term Strategies Tirzepatide: The Game-Changing Weight Loss

L., Walborg, E

Some patients may experience mild side effects, such as nausea, vomiting, diarrhea, or constipation, especially when first starting the treatment

These are classic signs of xerostomia

The autophagy adaptor p62/SQSTM1, essential for targeting ubiquitinated substrates to autophagosomes, is mutated in ALS and FTD, where impaired p62 function results in aggregation-prone protein accumulation and neuronal toxicity

SURMOUNT-5, published in 2025, confirmed tirzepatide outperformed semaglutide head-to-head (20.2% vs 13.7% over 72 weeks)

The benefit is obvious: smaller injection volumes mean less liquid under the skin, which can reduce injection site reactions and discomfort